These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26370730)

  • 1. Adrenal gland: Cancer target of mitotane identified.
    Holmes D
    Nat Rev Endocrinol; 2015 Nov; 11(11):631. PubMed ID: 26370730
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenal carcinoma.
    Freeman DA
    Curr Ther Endocrinol Metab; 1997; 6():173-5. PubMed ID: 9174731
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of mitotane therapy in dogs with pituitary dependent Cushing syndrome on the adrenal gland size--an ultrasonographic study].
    Hörauf A; Reusch C
    Schweiz Arch Tierheilkd; 1999; 141(5):239-45. PubMed ID: 10354742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog.
    Lee YM; Kang BT; Jung DI; Park C; Kim HJ; Kim JW; Lim CY; Park EH; Park HM
    J Vet Sci; 2005 Dec; 6(4):363-6. PubMed ID: 16294004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained remission of metastatic adrenal carcinoma during long-term administration of low-dose mitotane.
    Ilias I; Alevizaki M; Philippou G; Anastasiou E; Souvatzoglou A
    J Endocrinol Invest; 2001; 24(7):532-5. PubMed ID: 11508789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of adjuvant mitotane therapy following resection of adrenal cancer.
    Terzolo M; Ardito A; Zaggia B; Laino F; Germano A; De Francia S; Daffara F; Berruti A
    Endocrine; 2012 Dec; 42(3):521-5. PubMed ID: 22706605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocortical carcinoma mimicking pheochromocytoma on iodine 123-labeled metaiodobenzylguanidine scintigraphy.
    Nowak KM; Łebek-Szatańska A; Samsel R; Roszkowska-Purska K; Ćwikła JB; Papierska L
    Pol Arch Intern Med; 2019 Nov; 129(11):822-823. PubMed ID: 31469118
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells.
    Sbiera S; Leich E; Liebisch G; Sbiera I; Schirbel A; Wiemer L; Matysik S; Eckhardt C; Gardill F; Gehl A; Kendl S; Weigand I; Bala M; Ronchi CL; Deutschbein T; Schmitz G; Rosenwald A; Allolio B; Fassnacht M; Kroiss M
    Endocrinology; 2015 Nov; 156(11):3895-908. PubMed ID: 26305886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for mitotane activity: development of analogs for treatment of adrenal cancer.
    Schteingart DE; Sinsheimer JE; Benitez RS; Homan DF; Johnson TD; Counsell RE
    Anticancer Res; 2012 Jul; 32(7):2711-20. PubMed ID: 22753730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Normalisation of contralateral adrenal function after long-term mitotane therapy in a girl after surgical treatment of adrenocortical carcinoma].
    Lecka A; Ginalska-Malinowska M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):234-6. PubMed ID: 17020662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal adrenal function in an infant following a pregnancy complicated by maternal adrenal cortical carcinoma and mitotane exposure.
    Kojori F; Cronin CM; Salamon E; Burym C; Sellers EA
    J Pediatr Endocrinol Metab; 2011; 24(3-4):203-4. PubMed ID: 21648293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A young woman with a severe bilateral pneumonia as the presenting sign of an adrenal carcinoma.
    Chamuleau SA; Corssmit EP; Pereira AM; van de Berg BT; Siegert CE
    Neth J Med; 2008 Mar; 66(3):121-4. PubMed ID: 18349468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High (18)F-FDG uptake by the remaining adrenal gland four months after surgery and initiation of mitotane treatment in two patients with adrenocortical carcinoma.
    Mpanaka I; Lyra VD; Kaltsas G; Chatziioannou SN
    Hell J Nucl Med; 2011; 14(2):168-72. PubMed ID: 21761022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of postoperative recurrence of malignant tumors of adrenal glands].
    Kvacheniuk AN
    Klin Khir; 2004 Feb; (2):33-5. PubMed ID: 15124473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant mitotane therapy of adrenal cancer - use and controversy.
    Schteingart DE
    N Engl J Med; 2007 Jun; 356(23):2415-8. PubMed ID: 17554125
    [No Abstract]   [Full Text] [Related]  

  • 16. o,p'DDD therapy in invasive adrenocortical carcinoma.
    Becker D; Schumacher OP
    Ann Intern Med; 1975 May; 82(5):677-9. PubMed ID: 1137262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment--Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?
    Barzon L; Fallo F; Sonino N; Daniele O; Boscaro M
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1488-9. PubMed ID: 10199802
    [No Abstract]   [Full Text] [Related]  

  • 18. [Deoxycorticosterone-producing adrenal tumor].
    Shibata H
    Nihon Rinsho; 2006 May; Suppl 1():641-4. PubMed ID: 16776237
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of Cushing's syndrome and adrenal cancer with O,p-DDD].
    Kinouchi T; Shimizu N; Ibayashi H; Demura H; Oshima H
    Horumon To Rinsho; 1982 Aug; 30(8):841-51. PubMed ID: 7139984
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mitotane in the treatment of adrenal carcinoma].
    Sane T
    Duodecim; 2010; 126(17):2040-6. PubMed ID: 21053521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.